GMO Defends Active Managers’ Weak 2014 Performance
From all of the rationalizing we’ve been seeing recently, it seems like active equity managers have been having lots of uncomfortable conversations with their clients. The latest comes from Neil Constable, who leads quantitative research for GMO’s global equity team, and Matt Kadnar, a member of GMO’s asset allocation team, in their aptly named white paper ‘Is Skill Dead?’
“In today’s increasingly short-term-oriented investment culture, winning stock pickers are deemed to have exhibited superior foresight and brilliance while the losers . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.